Contents
Special Issue Topic

Advances in Oral Cancer: Prevention, Diagnosis, and Therapeutics

Submission Deadline: December 31, 2024

Guest Editor

Dr. Luca Fiorillo E-Mail

Research Assistant and Adjunct Professor of Prosthodontics (MED/28), Department of Biomedical and Dental Sciences, Morphological and Functional Images, School of Dentistry University of Messina, Messina, Italy

About the Special lssue

Oral cancer represents a significant global health challenge due to its high morbidity and mortality rates. In response to the pressing need for advancements in this field, we are pleased to announce the special issue, “Advances in Oral Cancer: Prevention, Diagnosis, and Therapeutics.” This issue aims to serve as a comprehensive platform for disseminating cutting-edge research addressing the multifaceted challenges of oral cancer. Our scope encompasses many topics, including identifying novel biomarkers for early detection, advancements in imaging technologies, innovative surgical techniques, targeted therapies development, and immunotherapy’s emerging role in oral cancer treatment.

We prioritize original research articles that contribute novel findings, aiming to enhance our understanding of oral cancer’s molecular and genetic underpinnings. Epidemiological studies shedding light on risk factors and prevention strategies and clinical trials evaluating new treatment modalities are highly encouraged. Additionally, we welcome high-quality review articles that critically assess existing literature and provide novel viewpoints on current controversies and future directions in oral cancer research.

To ensure a diverse and international representation, we seek contributions from researchers worldwide. This approach aims to foster collaborative efforts and ensure the global relevance and applicability of the findings presented in this issue.

Keywords: Oral cancer, biomarkers, early detection, imaging technologies, targeted therapies, immunotherapy, surgical techniques, epidemiology

Published Articles

Open Access Original Article
Cytotoxic effects of opiate agonist loperamide hydrochloride on human oral cancer cells—an invitro study
Aim: Loperamide hydrochloride (HCl), a peripheral opioid receptor agonist primarily used as an antidiarrheal drug, has been reported to induce apoptosis in various cancer cell lines. However, its
Published: April 02, 2025 Explor Med. 2025;6:1001301
242 7 0
Open Access Original Article
Feasibility of cinobufacini for the treatment of oral premalignant lesions: an open-label pilot trial
Aim: This study aimed to explore the feasibility and preliminary efficacy of cinobufacini in patients with oral premalignant lesions (OPLs). Methods: Patients with histologically confirmed
Published: January 09, 2025 Explor Med. 2025;6:1001269
547 20 0
Open Access Review
Risk factors, prevention, diagnosis, and immunotherapy’s involvement in the fight against oral cancer: a comprehensive review
Oral cancer is rare in Western nations but widespread in high-risk regions around the globe. Risk factors, such as tobacco usage, alcohol intake, and betel nut chewing, enhance the chance of the ill
Published: January 10, 2025 Explor Med. 2025;6:1001270
974 22 0